• LY2886721: BACE Inhibitor Workflows for Alzheimer’s Research

  2026-06-10

  LY2886721 delivers precise, dose-dependent BACE1 inhibition, enabling researchers to model amyloid beta reduction without compromising synaptic function. This guide translates the latest findings and practical workflows into actionable protocols for Alzheimer's disease research.

• Localized Muscle BDNF Release Orchestrates Postsynaptic NMJ

  2026-06-10

  This study uncovers the spatially restricted, calcium-dependent release of muscle-generated BDNF as a critical regulator of postsynaptic acetylcholine receptor cluster formation at vertebrate neuromuscular junctions. The findings clarify how subcellular BDNF trafficking and proteolytic processing coordinate early synaptic assembly, providing mechanistic insight for future research into synaptic development and modulation.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Imaging Power

  2026-06-09

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) combines real-time fluorescent tracking with high-sensitivity bioluminescence, enabling streamlined optimization of mRNA delivery and expression. Its advanced modifications minimize innate immune activation and maximize translation, making it a top choice for gene therapy research and high-throughput assay development.

• Phenothiazines Boost Macrophage Antibacterial Action via ROS

  2026-06-09

  A recent study reveals that phenothiazines, including dopamine receptor antagonists like Chlorpromazine HCl, enhance macrophage antibacterial capacity by stimulating reactive oxygen species (ROS) production and autophagy. These findings highlight new host-directed therapeutic avenues against antibiotic-resistant and intracellular bacterial infections.

• Arachidonic Acid Supplementation Accelerates Humoral Immunit

  2026-06-08

  The referenced study reveals that dietary arachidonic acid (ARA) supplementation significantly enhances the speed and magnitude of neutralizing antibody production following rabies vaccination in mice and humans. These findings highlight the potential of polyunsaturated fatty acids as modulators of vaccine-induced humoral immunity, with implications for optimizing vaccine efficacy and immunization strategies.

• PFHxS Disrupts Lipid Homeostasis via PPARα in Zebrafish Larv

  2026-06-08

  The reference study demonstrates that perfluorohexanesulfonic acid (PFHxS) disrupts lipid homeostasis in zebrafish larvae at environmentally relevant concentrations by activating peroxisome proliferator-activated receptor alpha (PPARα). Integrative lipidomic and transcriptomic analyses reveal PPARα as a critical molecular target, with pharmacological antagonism rescuing key lipid disturbances, thus clarifying mechanisms underlying PFAS-induced metabolic effects in vivo.

• Applied Use of α-Linolenic Acid: Protocols and Innovations

  2026-06-07

  Harnessing α-Linolenic Acid (ALA) unlocks new precision in lipid metabolism and immunometabolism studies. This guide details optimized workflows, cross-domain insights, and troubleshooting tactics that maximize research value using APExBIO’s ALA.

• (-)-JQ1 (SKU A8181): Precision Control in BET Inhibition Ass

  2026-06-06

  This article examines the role of (-)-JQ1 (SKU A8181) as the definitive inactive control in BET bromodomain research, focusing on laboratory scenarios that impact data specificity and assay reproducibility. Integrating recent literature and validated protocols, it demonstrates how (-)-JQ1 enhances experimental confidence for cancer biology and epigenetics workflows.

• GOT1 Inhibition by Ziprasidone Disrupts Glutamine Metabolism

  2026-06-05

  The referenced study uncovers ziprasidone as a non-competitive inhibitor of GOT1, leading to metabolic reprogramming and suppressed proliferation in pancreatic ductal adenocarcinoma (PDAC) cells. This work highlights GOT1 as a promising therapeutic target and elucidates mechanisms by which glutamine metabolism sustains tumor growth.

• Optimizing Cell Lysis with NP-40 Lysis Buffer: Protocols & I

  2026-06-05

  NP-40 Lysis Buffer enables efficient, non-denaturing protein extraction from diverse biological sources while preserving native protein complexes. Discover workflow enhancements, troubleshooting strategies, and experimental insights that directly support robust immunoprecipitation and neuroinflammation research.

• Thymoquinone in Cardioprotection: Pathway Modulation and Tra

  2026-06-04

  Discover the multifaceted action of thymoquinone, a potent small-molecule probe, as a modulator of cardiotoxicity pathways. This article uniquely examines how thymoquinone's mechanism—beyond classic antioxidant roles—enables advanced experimental designs in cardiovascular research.

• OSMI-1: Precision O-GlcNAc Transferase Inhibition in Ferropt

  2026-06-04

  Explore how OSMI-1, a leading O-GlcNAc transferase inhibitor, enables unprecedented mechanistic insights into ferroptosis and protein O-GlcNAcylation. This article bridges assay optimization with emerging disease models, offering novel perspectives beyond current literature.

• Omeprazole (A2845): Technical Guidance for Gastric Acid Rese

  2026-06-03

  Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor for controlled research on gastric acid secretion and antiulcer mechanisms. It is best suited for in vitro and preclinical workflows, not for diagnostic or therapeutic use. Proper handling and protocol adherence are essential to ensure reliable results in gastric acid-related studies.

• Dietary Arachidonic Acid Enhances Vaccine-Induced Humoral Im

  2026-06-03

  This study demonstrates that dietary arachidonic acid supplementation significantly accelerates and amplifies the humoral immune response to rabies vaccination in both mice and humans. The mechanistic insight into lymph node enrichment and metabolite-driven B cell activation highlights new strategies for modulating vaccine efficacy and optimizing immune responses.

• BML-277: A Selective Chk2 Inhibitor for DNA Damage Research

  2026-06-02

  BML-277 is redefining DNA damage response research with its high potency and selectivity as a Chk2 inhibitor, offering robust tools for radioprotection and genome stability assays. Its ATP-competitive inhibition and nanomolar efficacy enable precise interrogation of checkpoint pathways in cancer and senescence models.

16931 records 1/1129 page Next 12345 下5页 Last page